Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

These medtech stocks performed the best in 2020

January 15, 2021 By Sean Whooley

Abbott coronavirus tests

[Image from Abbott]

Abbott

Share price on Dec. 31, 2019: $86.84

Share price on Dec. 31, 2020: $109.49

Change: +26%

 

Already one of medtech’s big names, Abbott (NYSE:ABT) came to center-stage across 2020 as it took up a major role in the battle against COVID-19.

Staying two steps ahead, the company began tracking the virus in China at the end of 2019 and into early 2020 and, by February, it had an internal meeting to discuss its plan of action as the rapid spread reached the U.S. and the World Health Organization declared the COVID-19 outbreak a pandemic in March.

“We knew this virus was different. The outcome was spreading across the globe,” Andrea Wainer, executive VP of rapid and molecular diagnostics at Abbott, said during a CES 2021 panel. “Diagnostic players were going to need to play a role.”

Abbott developed a number of laboratory-based COVID-19 tests but perhaps its most vital innovation over 2020 was its BinaxNow COVID-19 Ag Card — a speedy antigen test for the virus that can be directly read off the testing card. BinaxNow received FDA emergency use authorization in August 2020 and soon was the subject of a number of federal government orders. Abbott most recently received EUA for virtually-guided, at-home use of the BinaxNow test.

The company’s diagnostic exploits led to Wall Street-beating quarterly performances, raised guidances and produced a 25% raised quarterly dividend, most recently.

In addition to its COVID-19-related production, Abbott remained on top in other spaces, with successes including:

  • FDA 510(k) clearance for its rapid handheld traumatic brain injury (TBI) blood test.
  • Multiple approvals for the FreeStyle Libre 2 continuous glucose monitor.
  • 2020 Prix Galien USA Award for Best Medical Technology for its MitraClip system.

With the pandemic carrying over into 2021, Abbott’s diagnostic prowess will likely continue to be relied upon, as will its innovations across the medtech space.

Next>>

Pages: 1 2 3 4 5 6 7 8 9 10 11

Related Articles Read More >

BinaxNow COVID-19 Ag Card
FDA issues new COVID-19 testing guidance to avoid false negatives
FDA logo
FDA’s breakthrough medical device designations tally nears 700
A portrait of Lifecore Biomedical CEO Jim Hall
Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
A lateral flow assay test for measuring COVID-19 immunity
COVID-19 immunity test developers at MIT seek diagnostic manufacturer

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech